Jarisch-herxheimer reaction triggered by group B streptococcus intrapartum antibiotic prophylaxis

Obstetrics and Gynecology

Volumn 116, Issue 2 PART 2, 2010, Pages 552-556

  Rac, Martha W F ^a   Greer, Laura G ^a   Wendel, George D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BENZATHINE PENICILLIN; BETA LACTAM ANTIBIOTIC; PENICILLIN G;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CESAREAN SECTION; CONGENITAL SYPHILIS; DIFFERENTIAL DIAGNOSIS; FEMALE; FETUS HEART RATE; FEVER; GENITAL HERPES; GROUP B STREPTOCOCCAL INFECTION; HERXHEIMER REACTION; HUMAN; INTRAPARTUM CARE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; SECONDARY SYPHILIS; STREPTOCOCCUS AGALACTIAE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; FEVER; HEART RATE, FETAL; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SYPHILIS; SYPHILIS, CONGENITAL; YOUNG ADULT;

EID: 77955159580     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181e7d065     Document Type: Article

References (8)

1. Center for Disease Control and Prevention. Sexually transmitted diseases surveillance 2008. Atlanta (GA): U.S. Department of Health and Human Services; November 2009. Available at: http://www.cdc.gov/std/stats08/syphilis.htm. Retrieved February 15, 2010.
2. Center for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 2006, 55 (RR-11), 1-94.
3. Brown ST. Adverse reactions in syphilis therapy. J Am Vener Dis Assoc 1976;3:172-175
4. Klein VR, Cox SM, Mitchell MD, Wendel GD Jr. The Jarish-Herxheimer reaction complicating syphilotherapy in pregnancy. Obstet Gynecol 1990;75:375-380
5. Myles TD, Elam G, Park-Hwang E, Nguyen T. The Jarish-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis. Obstet Gynecol 1998;92: 859-864
6. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. MMWR Recomm Rep 2002;51(RR-11):1-18.
7. Wendel GD Jr, Leveno KJ, Sanchez PJ, Jackson GL, McIntire DD, Siegel JD. Prevention of neonatal group B streptococcal disease: A combined intrapartum and neonatal protocol. Am J Obstet Gynecol 2002;186:618-626
8. Rein MF. Biopharmacology of syphilotherapy. J Am Vener Dis Assoc 1976;3:109-127